Can-Fite BioPharma Ltd.CANFNYSE
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, above historical average, structural decline.
Left:
||||
Year-over-year operating income growth rate
Latest
0.79%
↑ 111% above average
Average (9y)
-7.27%
Historical baseline
Range
High:26.60%
Low:-121.78%
CAGR
-24.6%
Structural decline
| Period | Value |
|---|---|
| 2024 | 0.79% |
| 2023 | 18.83% |
| 2022 | 21.38% |
| 2021 | 9.17% |
| 2020 | -17.76% |
| 2019 | -121.78% |
| 2018 | 26.60% |
| 2017 | 14.57% |
| 2016 | -34.59% |
| 2015 | 10.06% |